CL2017002884A1 - Tratamientos para el cancer - Google Patents

Tratamientos para el cancer

Info

Publication number
CL2017002884A1
CL2017002884A1 CL2017002884A CL2017002884A CL2017002884A1 CL 2017002884 A1 CL2017002884 A1 CL 2017002884A1 CL 2017002884 A CL2017002884 A CL 2017002884A CL 2017002884 A CL2017002884 A CL 2017002884A CL 2017002884 A1 CL2017002884 A1 CL 2017002884A1
Authority
CL
Chile
Prior art keywords
treatments
cancer
Prior art date
Application number
CL2017002884A
Other languages
English (en)
Inventor
Hugh Griffith
Chris Mcguigan
Chris Pepper
Original Assignee
NuCana plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NuCana plc filed Critical NuCana plc
Priority to CL2017002884A priority Critical patent/CL2017002884A1/es
Publication of CL2017002884A1 publication Critical patent/CL2017002884A1/es

Links

CL2017002884A 2017-11-13 2017-11-13 Tratamientos para el cancer CL2017002884A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2017002884A CL2017002884A1 (es) 2017-11-13 2017-11-13 Tratamientos para el cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2017002884A CL2017002884A1 (es) 2017-11-13 2017-11-13 Tratamientos para el cancer

Publications (1)

Publication Number Publication Date
CL2017002884A1 true CL2017002884A1 (es) 2018-07-06

Family

ID=63046526

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017002884A CL2017002884A1 (es) 2017-11-13 2017-11-13 Tratamientos para el cancer

Country Status (1)

Country Link
CL (1) CL2017002884A1 (es)

Similar Documents

Publication Publication Date Title
CL2018003443A1 (es) Tratamientos para el cancer.
IL261468A (en) Uterine cancer treatments
PT3283527T (pt) Terapêutica de combinação para o cancro
IL255217A0 (en) Cancer neoepitopes
IL255261A0 (en) Methods for treating cancer
EP3463464A4 (en) ASSOCIATION TREATMENT
PT3377516T (pt) Composição para o tratamento do cancro
IL247001A0 (en) Treatments for resistant acne
BR112017011771A2 (pt) métodos e composições para o tratamento de câncer
IL263802A (en) Cancer treatment combinations
PT3197456T (pt) Tratamentos de cancro
BR112017008399A2 (pt) abordagem de imunoterapia de combinação para tratamento de câncer
CL2015003281S1 (es) Parche para edema
PL3458052T3 (pl) Leczenie skojarzone nowotworu
EP3413927A4 (en) CANCER THERAPY
SI4119569T1 (sl) Konjugirane protismiselne spojine za uporabo v terapiji
EP3593139C0 (en) CANCER BIOMARKERS
DK3576740T3 (da) Cancerbehandling
BR112018000991A2 (pt) feniloxazolidinonas substituídas para terapia antimicrobiana
PL3134119T3 (pl) Leczenie nowotworu
EP3576791A4 (en) CALRETICULIN-MEDIATION CANCER TREATMENT
EP3591049A4 (en) LIMULA FACTOR (B) VARIANT
EP3541931A4 (en) COMBINED FRACTAL TREATMENT
LT3383385T (lt) Melflufeno dozavimo režimas vėžio atveju
DK3389717T3 (da) Neoadjuvansterapi for blærekræft